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Abstract
Background: The osmole gap is used routinely as a screening test for the presence of exogenous
osmotically active substances, such as the toxic alcohols ethylene glycol and methanol, particularly
when the ability to measure serum concentrations of the substances is not available. The objectives
of this study were: 1) to measure the diagnostic accuracy of the osmole gap for screening for
ethylene glycol and methanol exposure, and 2) to identify whether a recently proposed
modification of the ethanol coefficient affects the diagnostic accuracy.
Methods:  Electronic laboratory records from two tertiary-care hospitals were searched to
identify all patients for whom a serum ethylene glycol and methanol measurement was ordered
between January 1, 1996 and March 31, 2002. Cases were eligible for analysis if serum sodium,
blood urea nitrogen, glucose, ethanol, ethylene glycol, methanol, and osmolality were measured
simultaneously. Serum molarity was calculated using the Smithline and Gardner equation and
ethanol coefficients of 1 and 1.25 mOsm/mM. The diagnostic accuracy of the osmole gap was
evaluated for identifying patients with toxic alcohol levels above the recommended threshold for
antidotal therapy and hemodialysis using receiver-operator characteristic curves, likelihood ratios,
and positive and negative predictive values.
Results: One hundred and thirty-one patients were included in the analysis, 20 of whom had
ethylene glycol or methanol serum concentrations above the threshold for antidotal therapy. The
use of an ethanol coefficient of 1.25 mOsm/mM yielded higher specificities and positive predictive
values, without affecting sensitivity and negative predictive values. Employing an osmole gap
threshold of 10 for the identification of patients requiring antidotal therapy resulted in a sensitivity
of 0.9 and 0.85, and a specificity of 0.22 and 0. 5, with equations 1 and 2 respectively. The sensitivity
increased to 1 for both equations for the identification of patients requiring dialysis.
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Conclusion: In this sample, an osmole gap threshold of 10 has a sensitivity and negative predictive
value of 1 for identifying patients for whom hemodialysis is recommended, independent of the
ethanol coefficient applied. In patients potentially requiring antidotal therapy, applying an ethanol
coefficient of 1.25 resulted in a higher specificity and positive predictive value without
compromising the sensitivity.
Background
Serum osmolality can be measured directly (the 'meas-
ured osmolality') using osmometry, or estimated based
on the direct measurement of the concentrations of the
principle osmotically active substances (i.e. sodium, glu-
cose, blood urea nitrogen, and ethanol) and then substi-
tuting these values into a formula to determine the
'calculated molarity'. The difference between the meas-
ured osmolality and the calculated molarity is referred to
as the osmole gap [1,2]. The osmole gap is routinely used
to screen patients for the presence of other exogenous
osmotically active substances such as ethylene glycol and
methanol, particularly when the ability to measure the
serum concentrations of these substances is not available.
Screening and diagnostic tests are generally used to clas-
sify asymptomatic patients with respect to the likelihood
of the presence of a disease [3]. Screening tests are ideally
suited to detect diseases with a latent period between
onset of disease (or time of exposure) and the develop-
ment of overt symptoms, especially when the early diag-
nosis and initiation of therapy improves prognosis [4,5].
Toxic alcohol exposure meets these criteria given that seri-
ous toxicity is preventable with early diagnosis and initia-
tion of antidotal therapy. The rapid and accurate
diagnosis of toxic alcohol poisoning is therefore crucial to
prevent serious adverse outcomes.
In a recent review of the medical literature we did not
identify any well-designed studies of the osmole gap as a
screening test for toxic alcohol exposure [1]. Numerous
studies have either proposed a formula or formulae for
estimating serum osmolality [6-14], evaluated the rela-
tionship between measured osmolality and calculated
molarity in non-poisoned patient [6,7,10-12,14,15], or
tested the ability of the osmole gap to predict serum etha-
nol concentrations in patients exposed only to ethanol
[13,16-22]. While none of these studies provide evidence
of the diagnostic performance of the osmole gap, they
form the basis for the widespread use of the osmole gap as
a screening test for toxic alcohol exposure.
To evaluate the osmole gap as a screening test, its perform-
ance must be compared to a gold standard diagnostic test
(e.g. gas chromatography) in a sufficient number of
patients at all levels of exposure with a specific definition
of what constitutes a positive test (i.e. the diagnostic
threshold of the osmole gap) [23]. We have not found any
studies published to date that satisfy these criteria. There-
fore, the objectives of this study were: 1) to measure the
diagnostic accuracy of the osmole gap for screening for
ethylene glycol and methanol exposure, and 2) to identify
whether a recently proposed modification of the ethanol
coefficient affects this diagnostic accuracy.
Methods
Setting
We conducted a retrospective analysis of laboratory
records available from two tertiary care hospitals. Elec-
tronic laboratory records from both hospitals were
searched to identify all patients with a serum ethylene gly-
col and methanol measurement recorded between Janu-
ary 1, 1996 and March 31, 2002. This study was approved
by the institutional ethics review boards.
Selection of Study Subjects
Cases were only eligible for inclusion in the analysis if
serum sodium, blood urea nitrogen, glucose, ethanol, eth-
ylene glycol, methanol, and serum osmolality measured
using freezing point depression were measured on blood
drawn at the same time. Cases were excluded if additional
laboratory results indicated lipemia, ketosis, dysproteine-
mia, or hemolysis. Cases with a serum ethylene glycol and
methanol level of 0 mmol/L and an arterial pH below
7.30 were deemed to have either a significant delay
between exposure and clinical assessment, or another
cause for the acidemia, and were also excluded from the
analysis. In the event of multiple hospital visits only the
first visit was included in the analysis.
Methods of Measurement
In both hospitals, serum electrolytes, BUN, glucose and
ethanol concentrations were determined using a high vol-
ume analyzer (Beckman CX7, Model 7566, Beckman
Instruments, Inc. Fullerton, CA, USA) and serum osmola-
lity was measured by freezing point depression (Advanced
Micro Osmometer model 3300, Advanced Instruments
Inc., Norwood, MA, USA). Serum concentrations of ethyl-
ene glycol and methanol were determined using gas chro-
matography (Hewlett Packard 5890A Gas
Chromatograph, Hewlett Packard, Avondale, PA, USA),
predefined as the gold standard for the diagnosis of toxic
alcohol exposure.BMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
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Data Analysis
The calculated molarity was obtained using the equation
proposed by Smithline and Gardner which was deemed to
be the equation applied most frequently by clinicians
[9,24,25]. The contribution of ethanol to the osmolarity
of serum was incorporated using two different coeffi-
cients: 1 mOsm/mM (equation 1), as has been standard
practice [13], and 1.25 mOsm/mM (equation 2) as pro-
posed by Purssell et al. [18,26]. The osmole gap was then
calculated for each patient using both equations at the
first instance when all required laboratory parameters
were measured simultaneously, provided that this
occurred within 24 hours of the first recorded laboratory
measurement.
For the purposes of this analysis, a "positive exposure"
was defined a priori as any serum ethylene glycol or meth-
anol concentration above the recommended treatment
thresholds. Specifically, we evaluated the ability of the
osmole gap to identify patients with a serum ethylene gly-
col or methanol concentration above which antidotal
therapy (3 mmol/L and 6 mmol/L, respectively) or hemo-
dialysis (8 mmol/L and 15 mmol/L, respectively) is rec-
ommended [27,28].
The diagnostic accuracy of each equation was determined
for all possible cut-offs of the osmole gap using Receiver-
Operator Characteristics (ROC) curves. Because an
osmole gap of 10 is the most common clinically applied
cut-off for the diagnosis of potential toxic alcohol poison-
ing [27,29], we calculated the sensitivity, specificity, and
positive and negative likelihood ratios of the test at this
threshold. If the sensitivity was < 1.0, the hospital chart of
every patient falsely classified as unexposed using this cut-
off was reviewed to characterize their clinical course and
outcome. Based on the conclusions of a study by
Aabakken et al. [15], we also performed a secondary
exploratory analysis of the diagnostic performance of an
osmole gap of 20.
Receiver-operator characteristics curves were plotted using
both equations for each treatment threshold. The area
under the curve (AUC), or diagnostic index, was then cal-
culated for each ROC curve. Non-parametric statistical
analyses were used to determine whether the AUC for
each ROC curve differed significantly from 0.5. In order to
identify the equation with the best diagnostic perform-
ance, the difference in the diagnostic index of each equa-
tion was compared, using a non-parametric method that
accounts for correlation within individuals [30]. The pos-
itive predictive value (PPV) and negative predictive value
(NPV) of each equation was also calculated and plotted
against all possible osmole gap cut-offs. All analyses were
performed using SPSS v 12.0. (SPSS Inc., Chicago, IL,
USA. 2003) and SAS v.8.02 (SAS Institute, Cary, NC, USA.
1999).
Results
Characteristics of Study Subjects
We identified 235 patients with 240 hospital visits during
which serum ethylene glycol and methanol levels were
measured by gas chromatography within 24 hours of their
first laboratory results (Figure 1). Five patients had two
separate hospital visits with toxic alcohols measurements,
so only the first visit was included in the analysis. One
hundred and three patients were excluded because they
did not have all required measurements performed on
serum drawn at the same time; 51 had toxic alcohol levels
requisitioned but not measured suggesting that they were
deemed to not be required (i.e. very low pre-test probabil-
ity of exposure) and 37 had undetectable ethylene glycol
and methanol concentrations. The remaining 15 patients
had detectable toxic alcohol serum concentrations, nine
of which exceeded the threshold for antidotal therapy. An
osmole gap prior to the measurement of the toxic alcohol
concentration could only be calculated for two of these
patients, both of which exceeded 10 using both equation
1 and 2. One additional patient was excluded due to the
presence of acidosis and no detectable toxic alcohol.
The final study population therefore included 131
patients, 20 of whom were deemed 'exposed' (i.e. had
concentrations above the threshold for antidotal therapy)
to either ethylene glycol (n = 10), methanol (n = 9), or
both (n = 1). The only patient positive for exposure to
both ethylene glycol and methanol had serum concentra-
tions of 3 mmol/L and 122 mmol/L, respectively. Seven-
teen patients had serum ethylene glycol (n = 7) and
methanol (n = 10) concentrations above the threshold for
hemodialysis.
All detectable serum ethylene glycol concentrations
exceeded the threshold for treatment (i.e. 3 mmol/L),
ranging from 3 to 68.7 mmol/L (median 6, IQR 19.3).
Serum methanol concentrations in patients considered
exposed to methanol ranged from 16 to 202 mmol/L
(median 56.4, IQR 100.3). Fourteen additional patients
had methanol levels below the threshold for antidotal
therapy, 11 of which had an osmole gap > 10 derived
using equation 1 (mean OG 19.3, SD 15.4) versus only
eight using equation 2 (mean OG 13.1, SD 18.1). These
patients were therefore considered false-positive expo-
sures. Seventy-six patients (58%) had positive serum eth-
anol levels (mean 44.2 mmol/L; range 0.3 to 135 mmol/
L), seven of which exceeded 100 mmol/L.
Main Results
The results of the primary analyses of the osmole gap for
identifying patients with toxic alcohol concentrationsBMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
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above the threshold for antidotal therapy are illustrated in
Figure 2, and the associated diagnostic indices are pre-
sented in Table 2. Both equations resulted in an AUC that
differed significantly from 0.5 (p < 0.001) suggesting that
the osmole gap provides at least some discriminatory
diagnostic information. Although equation 2 resulted in a
higher diagnostic index relative to equation 1 (0.785 ver-
sus 0.736, respectively), this difference was not statisti-
cally significant (two sided p = 0.06).
Although the ROC curves and diagnostic indices associ-
ated with the two equations were similar, there were dif-
ferences in their sensitivities and specificities at a given
osmole gap (Figure 2). Applying an osmole gap cut-off of
10 for the identification of patients requiring antidotal
therapy resulted in a sensitivity of 0.90 (95% CI, 0.68 –
0.99) with a corresponding specificity of only 0.22 (95%
CI, 0.14 – 0.30) (87/111 false positive diagnoses) with
equation 1. Equation 2 resulted in a slightly lower sensi-
tivity of 0.85 (95% CI, 0.62 – 0.97) as a result of 1 addi-
tional false-negative case), but a higher specificity of 0.50
(95% CI, 0.40 – 0.59). If applied clinically, the higher spe-
cificity of equation 2 would have resulted in 31 fewer
patients receiving a false-positive diagnoses, all of which
had serum ethanol concentrations >0 mmol/L. Equation
2 also produced more favourable positive (LR+) and neg-
Flow diagram outlining the derivation of the final study sample Figure 1
Flow diagram outlining the derivation of the final study sample. Shaded boxes represent patients considered to be 
'exposed' (i.e. ethylene glycol or methanol serum concentrations exceeding the threshold for antidotal therapy). Legend: All 
concentrations expressed as mmol/l. EG = ethylene glycol ME = methanol
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ative (LR-) likelihood ratios of 1.68 (95% CI, 1.29 – 2.16)
and 0.30 (95% CI, 0.10 – 0.72), respectively, versus 1.15
(95% CI, 0.96 – 1.36) and 0.46 (95% CI, 0.11 – 1.30)
respectively, for equation 1. Exploratory analysis of an
osmole gap cut-off of 20 proposed by Aabakken et al. [15]
resulted in a lower sensitivity with both equations 1 and 2
(0.65; 95% CI 0.41 – 0.85) and correspondingly more
false-negative diagnoses (n = 7), but a higher specificity
(0.60; 95% CI 0.51 – 0.69, and 0.75; 95% CI 0.66 – 0.83
with equations 1 and 2, respectively).
Consistent with the results for the threshold for antidotal
therapy, equation 2 resulted in a higher diagnostic index
relative to equation 1 for the identification of patients
requiring hemodialysis (0.827 versus 0.870, respectively);
however, this difference was not statistically significant (p
= 0.056) (Table 2). Figure 3 illustrates the ROC curves for
the identification of patients with serum ethylene glycol
or methanol concentrations above the threshold for
hemodialysis. A cut-off of 10 resulted in a sensitivity of
1.0 (95% CI, 0.80 – 1.00) for both equations, but equa-
tion 2 was more specific (0.51; 95% CI, 0.41 – 0.60 versus
0.23; 95% CI, 0.15 – 0.32). The positive and negative like-
lihood ratios for equation 2 at a cut-off of 10 were 2.04
(95% CI, 1.68 – 2.44) and 0, respectively. Applying an
osmole gap of 20 resulted in a decrease in sensitivity with
both equations (0.76; 95% CI 0.50 – 0.93) and a slight
improvement in specificity (0.61; 95% CI 0.52 – 0.70, and
0.76; 95% CI 0.67 – 0.83 with equation 1 and 2, respec-
tively).
The PPV and NPV of all osmole gap cut-offs derived using
both equations are illustrated in Figure 4. At an osmole
gap cut-off of 10, the NPV of equations 1 and 2 were 0.92
(95% CI, 0.75 – 0.99) and 0.95 (95% CI, 0.86 – 0.99),
respectively, for the identification of patients with levels
Receiver Operator Characteristics curves for the two equa- tions when used to identify patients with serum concentra- tions of ethylene glycol and methanol that exceed the  threshold at which hemodialysis is recommended Figure 3
Receiver Operator Characteristics curves for the 
two equations when used to identify patients with 
serum concentrations of ethylene glycol and metha-
nol that exceed the threshold at which hemodialysis 
is recommended
- - - - osmole gap derived using equation 1 (ethanol coeffi-
cient of 1)
----- osmole gap derived using equation 2 (ethanol coefficient 
of 1.25).
The points delineated by   and   indicate an osmole gap cut-
off of 10 derived using equations 1 and 2, respectively. The 
points delineated by   and  indicate an osmole gap cut-off of 
20 derived using equations 1 and 2, respectively.
Receiver Operator Characteristics curves for the two equa- tions when used to identify patients with serum concentra- tions of ethylene glycol and methanol that exceed the  threshold at which antidotal therapy is recommended Figure 2
Receiver Operator Characteristics curves for the 
two equations when used to identify patients with 
serum concentrations of ethylene glycol and metha-
nol that exceed the threshold at which antidotal 
therapy is recommended
- - - - osmole gap derived using equation 1 (ethanol coeffi-
cient of 1)
------ osmole gap derived using equation 2 (ethanol coeffi-
cient of 1.25).
The points delineated by   and   indicate the cut-off of 10 
derived using equations 1 and 2, respectively. The points 
delineated by   and  indicate the cut-off of 20 derived using 
equations 1 and 2, respectively.BMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
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above the threshold for antidotal therapy (Panel a). For
the identification of patients with levels above the hemo-
dialysis threshold (Panel b), both equations had a NPV of
1.0. The PPV of equation 2 was also consistently higher,
independent of the osmole gap cut-off.
Because a false negative diagnosis of toxic alcohol expo-
sure may result in potentially life-threatening or long-
term sequelae, we reviewed the health records of the three
patients with an osmole gap < 10 derived using either
equation despite a serum ethylene glycol concentration
above the threshold for antidotal therapy.
Clinical Summary of False-Negative Cases (osmole gap 
threshold 10)
Case 1
A 55 year old male was admitted to an emergency depart-
ment at least seven hours post-exposure to ethylene gly-
col, obtunded and requiring intubation. Initial laboratory
results revealed an anion gap metabolic acidosis (HCO3
- 3
mEq/L, anion gap 31.5) and an osmole gap of 143 (meas-
Table 1: Equations used to calculate the serum molarity prior to the calculation of the osmole gap. 
Equation Number Equation
1O s m c = 2 * Na (mEq/L) + BUN (mmol/L) + glucose (mmol/L) + ethanol (mmol/L)
2O s m c = 2 * Na (mEq/L) + BUN (mmol/L) + glucose (mmol/L) + 1.25 * ethanol (mmol/L)
Equation 2 in effect inflates the ethanol concentration by 25% prior to calculating the osmole gap, as proposed by Purssell et al.[18]
Osmc = calculated molarity; Na = sodium; BUN = blood urea nitrogen
To convert from SI units, use the following corrections: BUN/2.8 mg/dl, glucose/18.1 mg/dl, ethanol/0.217 mg/dl
The Positive Predictive Value and Negative Predictive Value of osmole gap values ranging between -10 and 30 to identify toxic  alcohol concentrations exceeding the antidotal therapy (Panel a) and hemodialysis (Panel b) thresholds Figure 4
The Positive Predictive Value and Negative Predictive Value of osmole gap values ranging between -10 and 30 
to identify toxic alcohol concentrations exceeding the antidotal therapy (Panel a) and hemodialysis (Panel b) 
thresholds
Black lines represent the positive predictive value.
Grey lines represent the negative predictive value.
- - - - osmole gap derived using equation 1 (ethanol coefficient of 1)
----- osmole gap derived using equation 2 (ethanol coefficient of 1.25)BMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
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ured osmolality 446 mOsm/kg; calculated molarity 302.1
mOsm/L derived using equation 2). The patient was
treated with intravenous ethanol, thiamine and folate
prior to transfer to a tertiary care facility without confirm-
atory methanol or ethylene glycol concentrations. How-
ever, when all required laboratory parameters were
measured simultaneously, he had an osmole gap of 7.8
(derived using equation 2) and an ethylene glycol level of
6 mmol/L. The patient underwent 13.5 hours of dialysis
and developed acute renal failure with a peak creatinine of
1,410 mmol/L nine days post-exposure, and was dis-
charged from hospital 19 days post-exposure with a serum
creatinine of 613 mmol/L.
Case 2
A 51 year old female with a history of alcoholism, hepati-
tis C, hypertension, non-insulin dependent diabetes mel-
litus, and intravenous drug use was admitted to the
emergency department following a near drowning epi-
sode. Although she was initially unresponsive and cyan-
otic, upon arrival at the emergency department she was
alert but confused. Initial lab results revealed an anion gap
metabolic acidosis (pH 7.1, HCO3
- 11 mEq/L, anion gap
27) with an osmole gap of 19.2 calculated using equation
2. Three and one-half hours after admission (the time
point used in this analysis), her serum ethylene glycol,
methanol, and ethanol concentrations were 5 mmol/L, 0
mmol/L, 54 mmol/L, respectively, with a corresponding
osmole gap of 1.7 (calculated using equation 2). She did
not receive any further antidotal therapy or hemodialysis
and was discharged following two days of hospitalization
without any adverse sequelae.
Case 3
A 50 year old developmentally delayed male with a prior
history of ethylene glycol ingestion presented to the emer-
gency department approximately 7.5 hours after an inten-
tional ingestion of approximately 400 ml of ethylene
glycol. Twenty minutes after arrival, laboratory results
revealed an anion gap metabolic acidosis (arterial pH
7.27, HCO3
- 9.4 mEq/L, anion gap 18), an osmole gap of
9.8, and an ethylene glycol concentration of 5 mmol/L;
ethanol was undetectable. An ethanol infusion was initi-
ated within one hour of presentation followed four hours
later by five hours and forty minutes of hemodialysis. His
serum creatinine peaked five days post-exposure at 459
mmol/L, following which he recovered completely.
Discussion
This is the first study to evaluate the osmole gap as a
screening test for toxic alcohol exposure that conforms to
the STARD criteria for reporting studies of diagnostic accu-
racy [31]. In this sample, an osmole gap cut-off of 10
derived using the Smithline and Gardner equation with
ethanol coefficients of 1 and 1.25 resulted in a relatively
high sensitivity (> 0.85) but a low specificity (< 0.50) and
high NPVs for the identification of patients for whom
antidotal therapy for toxic alcohol poisoning would be
indicated. These results therefore indicate that although
this is not an ideal screening test, the osmole gap does
provide additional diagnostic information. Specifically, a
NPV of 0.95 for an osmole gap < 10 indicates a very high
probability that if a toxic alcohol has been ingested, the
serum level is below the threshold for antidotal therapy.
This analysis does not suggest that the osmole gap should
be used in isolation to provide the basis for discharging a
patient without further clinical investigation or evalua-
tion. However, it does indicate that the osmole gap does
provide some additional diagnostic and prognostic infor-
mation in terms of the probability that a patient will need
antidotal therapy or hemodialysis. Using other clinical
information and laboratory data in conjunction with the
osmole gap will increase the accuracy of the diagnosis.
Using equation 2 to account for the supramolar contribu-
tion of ethanol resulted in an increase in the specificity of
the osmole gap without a significant reduction in sensitiv-
ity. Although a screening test with a sensitivity of 1.0 is
most desirable in this clinical situation, achieving this
would result in a low specificity and a corresponding high
false-positive rate which could result in the unnecessary
initiation of treatment in these patients. Although antido-
tal treatment with either intravenous ethanol or fomepiz-
ole is relatively benign, the cost-effectiveness of any
screening test must incorporate all costs and potential
risks of misdiagnosis and inappropriate initiation of treat-
Table 2: Area under the curve (diagnostic index) for osmole gap to identify toxic alcohol exposure.
Exposure Threshold AUC (95% CI) p value AUC2 - AUC1 (95% CI) p value
ANTIDOTAL THERAPY
Equation 1 0.736 (0.599, 0.873) < 0.001 0.049 (-0.001, 0.099) 0.057
Equation 2 0.785 (0.665, 0.905) < 0.001
HEMODIALYSIS
Equation 1 0.827 (0.715, 0.939) < 0.001 0.043 (-0.001, 0.086) 0.056
Equation 2 0.870 (0.784, 0.956) < 0.001
AUC = area under the curve; SE = standard error; CI = confidence intervalBMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
Page 8 of 10
(page number not for citation purposes)
ment which might include unnecessary hospitalization,
treatment, or transfer by air or road ambulance.
Of the three exposed patients who may have been falsely
diagnosed as unexposed using an osmole gap cut-off of
10, two had an elevated osmole gap upon presentation to
the emergency department and would likely have been
correctly diagnosed as exposed. The third patient had a
compelling history of significant ethylene glycol inges-
tion, an osmole gap of 9.8, and an anion gap metabolic
acidosis when they arrived at the emergency room and
would also likely have been correctly diagnosed based on
other available information.
A survey of studies of diagnostic accuracy published in
four major journals concluded that the methodologies
employed were generally inadequate to answer the ques-
tions posed [32]. The results of that survey lead to the
development of the Standards for Reporting Diagnostic
Accuracy (STARD) statement which consists of 25 criteria
that should be adhered to when evaluating the diagnostic
accuracy of a test [31,33]. This is the first formal evalua-
tion of the diagnostic accuracy of the osmole gap that: i)
includes subjects with all levels of exposure to ethylene
glycol or methanol; ii) evaluates the osmole gap com-
pared to the gold standard; and iii) conforms to essen-
tially all other STARD criteria.
One of the necessary components of any screening test
evaluation is a clear and valid definition of what consti-
tutes a positive test [23]. Although Aabakken et al. pro-
posed a threshold of 20 using a different equation to
calculate serum osmolarity, this was based on 177 consec-
utive patients admitted to an ED (mean age 65 years)
without any exposure to ethylene glycol or methanol [15].
Given that the normal range for the osmole gap may be
higher in patients older than 60 years of age and that the
osmole gap is generally used in conjunction with other
diagnostic information, we felt that it is unlikely that this
threshold is applicable to the diagnosis of toxic alcohol
poisoning [34]. In support of this, although applying an
osmole gap cut-off of 20 in our sample resulted in higher
specificity relative to an osmole gap of 10, it had a lower
sensitivity that corresponded to six additional false-nega-
tive diagnoses [15]. This reduction in sensitivity is con-
cerning in this clinical scenario, given the potential
serious and fatal ramifications of a false-negative diagno-
sis.
The diagnostic performance of the osmole gap is related to
both the cut-off of the test and serum level being detected.
Because we were unable to find any other empiric evalua-
tion of the most appropriate osmole gap cut-off for the
diagnosis of toxic alcohol poisoning, we elected to evalu-
ate all possible cut-offs using ROC curves, and then specif-
ically evaluate the clinically accepted osmole gap
threshold of 10. Additionally, there is limited evidence
supporting the current recommended thresholds of ethyl-
ene glycol and methanol concentrations for initiating
antidotal therapy and hemodialysis that we used in this
analysis. If these thresholds are too conservative as has
been suggested, more liberal treatment thresholds would
improve the diagnostic performance of the osmole gap
[35].
Because the inclusion criteria applied in this study
required that both ethylene glycol and methanol be meas-
ured by gas chromatography, some patients may have had
a toxic alcohol level above the threshold for antidotal
therapy that was not measured. The diagnostic perform-
ance of the osmole gap may therefore be poorer if applied
to all patients with any suspicion of exposure, including
cases where exposure may have been potentially ruled
out, albeit erroneously, before specific serum concentra-
tion measurements are performed.
This highlights the importance of interpreting the result of
the osmole gap as it relates to other available information
to estimate the likelihood of a toxic alcohol exposure.
Information pertaining to the ingestion history, clinical
signs and symptoms (e.g. visual disturbances) and other
laboratory data including pH, HCO3
-, anion gap and uri-
nalysis should all be considered concurrently [36]. How-
ever, this study only evaluated the diagnostic accuracy of
the osmole gap alone measured within 24 hours of the
first recorded laboratory measurement. Consequently,
these results are likely an underestimate of the overall
clinical utility of the osmole gap when evaluated in con-
junction with other diagnostic information as early as
possible following exposure.
This study has three primary limitations. First, it is limited
by the use of retrospective data and the requirement that
all laboratory tests be performed on serum obtained
simultaneously; this resulted in the exclusion of 103 sub-
jects. However, to avoid making clinical assumptions
using only laboratory data, we pre-specified that all
required laboratory parameters had to be measured
simultaneously. Because these measurements were not
necessarily performed on the first blood sample obtained
upon presentation to the emergency room, we restricted
this analysis to only laboratory data collected within the
first 24 hours of the first available blood sample. The
rationale for this restriction was to mimic admission
results as closely as possible within the constraints of a ret-
rospective study. Realizing the critical importance of the
simultaneous evaluation of all laboratory parameters
immediately upon admission, and the time of the inges-
tion when interpreting the osmole gap, a prospectiveBMC Emergency Medicine 2008, 8:5 http://www.biomedcentral.com/1471-227X/8/5
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study is required to specifically address this methodologi-
cal issue.
The second limitation of the study is the potential for
referral or ascertainment bias. This sample only included
patients who had serum ethylene glycol and methanol
levels measured, which might suggest a high pre-test prob-
ability of exposure. However, ethylene glycol or methanol
was only detectable in 34/131 (26%) patients. This inci-
dence of detectable toxic alcohol concentrations suggests
that the referral bias was not extreme and that the pre-test
probability of exposure in this sample of patients was
likely only moderate.
Finally, there is the potential for work-up bias. If an
osmole gap above a specific cut-off is used as a prerequi-
site to measuring toxic alcohols using gas chromatogra-
phy, this would tend to overstate the sensitivity of the test.
We cannot exclude this possibility, especially in patients
with toxic alcohol concentrations just above the threshold
for antidotal therapy. Although it is possible that some of
the 51 patients who had ethylene glycol and methanol
concentrations requisitioned but not measured may have
had elevated toxic alcohol concentrations despite an
osmole gap below 10, we believe that workup bias was
not significant in this dataset for several reasons. First, gas
chromatography was performed in 25 patients despite an
osmole gap below 10 calculated using equation 1, the
most commonly applied equation in clinical practice. Sec-
ond, we are not aware of any patient in either institution
during the study period with an osmole gap less than 10
that subsequently developed significant toxicity. And
finally, most of the cases with a detectable methanol con-
centration below the threshold for antidotal therapy had
an osmole gap > 10.
Conclusion
Toxic alcohol exposure is a clinical emergency requiring
rapid evaluation and initiation of treatment to prevent
serious morbidity and mortality. Unfortunately, making a
definitive diagnosis is often difficult given that the gold
standard test (i.e. gas chromatography) is not available at
most hospitals. As a result, the inexpensive and widely
available osmole gap remains part of the diagnostic strat-
egy for most emergency room physicians, despite two
important limitations [13,37]. First, the osmole gap lacks
specificity, given that it is also elevated in other clinical sit-
uations, e.g. diabetic ketoacidosis, circulatory shock, and
alcoholic acidosis [1]. Second, its wide normal range
renders it insensitive to small but potentially toxic con-
centrations of ethylene glycol in particular, but also meth-
anol [38]. Despite these limitations, until now there has
not been a rigorous, methodologically sound evaluation
of diagnostic accuracy of this test for the diagnosis of toxic
alcohol exposure.
The results of this analysis indicate that the osmole gap
does provide additional diagnostic information when
applied as a screening test for toxic alcohol poisoning, and
its' diagnostic accuracy improves when the supramolar
contribution of ethanol to serum molarity is taken into
account. However, these results do not support the use of
the osmole gap in isolation, and further support the con-
clusions of Krahn and Khajuria who suggest that these cal-
culations are only effective if they are validated on
appropriate reference populations, and if strict quality
control procedures are followed [39]. Therefore, a multi-
centre prospective evaluation of the osmole gap is
required to evaluate the overall clinical utility of the test,
taking into account the time since ingestion, other labora-
tory results, all available clinical diagnostic information
collected immediately upon admission, and institutional
differences.
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